Standard versus Newer Antibacterial Agents in the Treatment of Severe Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Randomized Trial of Trimethoprim-Sulfamethoxazole versus Ciprofloxacin
Clinical Infectious Diseases, 06/28/2010

1 Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin Full Text Annals of Clinical Microbiology and Antimicrobials, May 9, 2012    Free full text    Clinical Article

2 The Combination of Doripenem and Colistin Is Bactericidal and Synergistic against Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae Antimicrobial Agents and Chemotherapy, May 17, 2012    Clinical Article

3 Evaluation of a new interferon-gamma release assay and comparison to tuberculin skin test during a tuberculosis outbreak International Journal of Infectious Diseases, May 1, 2012

4 Effectiveness of Chlorhexidine oral decontamination in reducing the incidence of ventilator associated pneumonia: A meta-analysis. Full Text British Journal of Medical Practitioners, May 7, 2012    Free full text    Evidence Based Medicine    Clinical Article

5 Gastric Acid Suppression and Clostridium difficile Infection: Is There a Causal Connection Clinical Gastroenterology and Hepatology , April 24, 2012

6 Empiric guideline-recommended weight-based vancomycin dosing and mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study Full Text BMC Infectious Diseases, April 30, 2012    Free full text

7 Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial The Lancet Infectious Diseases, March 27, 2012    Clinical Article

8 Microbiological Aetiology, Epidemiology, and Clinical Profile of Prosthetic Joint Infections: Are Current Antibiotic Prophylaxis Guidelines Effective Antimicrobial Agents and Chemotherapy, May 2, 2012

9 Quality Assessment of U.S. Marketplace Vancomycin for Injection Products Using High-Resolution Liquid Chromatography-Mass Spectrometry and Potency Assays Antimicrobial Agents and Chemotherapy, May 18, 2012    Clinical Article

10 Timing of antibiotic administration and outcomes of hospitalized patients with community-acquired and healthcare-associated pneumonia Clinical Microbiology and Infection, April 25, 2012    Clinical Article

11 Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)-infected and HIV-uninfected persons Transplant Infectious Disease, May 3, 2012

12 A multicentre randomised controlled trial evaluating lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea in older people admitted to hospital: the PLACIDE study protocol Full Text BMC Infectious Diseases, May 9, 2012    Free full text

13 Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia Clinical Microbiology and Infection, April 17, 2012    Clinical Article

14 Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae American Journal of Infection Control, May 25, 2012    Clinical Article

15 Fidaxomicin: a guide to its use in Clostridium difficile infection Drugs & Therapy Perspectives, May 16, 2012    Clinical Article

16 Performances of the MALDI-TOF Mass Spectrometry system VITEK MS for the Rapid Identification of Bacteria in Routine Clinical Microbiology Journal of Clinical Microbiology, May 21, 2012

17 Antimicrobial-Resistant Strains of Clostridium difficile from North America Antimicrobial Agents and Chemotherapy, May 18, 2012

18 Time to positivity of blood cultures of different Candida species causing fungaemia Journal of Medical Microbiology, May 4, 2012

19 Use of interferon-gamma release assays in a health care worker screening program: Experience From a tertiary care centre in the United States Canadian Respiratory Journal, April 24, 2012    Clinical Article

20 Azithromycin to prevent Pseudomonas aeruginosa ventilator-associated pneumonia by inhibition of quorum sensing: a randomized controlled trial Intensive Care Medicine, April 30, 2012    Clinical Article